1. Home
  2. AUROW vs INM Comparison

AUROW vs INM Comparison

Compare AUROW & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc. Warrant

AUROW

Aurora Innovation Inc. Warrant

HOLD

Current Price

$0.29

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo InMed Pharmaceuticals Inc.

INM

InMed Pharmaceuticals Inc.

HOLD

Current Price

$1.20

Market Cap

3.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUROW
INM
Founded
2017
1981
Country
United States
Canada
Employees
1800
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
3.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AUROW
INM
Price
$0.29
$1.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
137.0K
195.0K
Earning Date
04-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,798,116.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$1.13
52 Week High
$3.00
$8.27

Technical Indicators

Market Signals
Indicator
AUROW
INM
Relative Strength Index (RSI) 41.37 39.21
Support Level $0.28 $1.20
Resistance Level $0.34 $1.36
Average True Range (ATR) 0.03 0.11
MACD 0.01 0.01
Stochastic Oscillator 27.86 9.72

Price Performance

Historical Comparison
AUROW
INM

About AUROW Aurora Innovation Inc. Warrant

Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Share on Social Networks: